Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.
Hellstrom
Wayne J G
WJ
Department of Urology, Tulane University Medical Center, New Orleans, Louisiana 70112, USA. whellst@tulane.edu
Gittelman
Marc
M
Karlin
Gary
G
Segerson
Thomas
T
Thibonnier
Marc
M
Taylor
Terry
T
Padma-Nathan
Harin
H
D004311:Double-Blind Method; D004562:Electrocardiography; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010410:Penile Erection / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos / Q000627:therapeutic use; D020127:Recovery of Function; D012449:Safety; D013450:Sulfones; D016896:Treatment Outcome; D014227:Triazines; D000069058:Vardenafil Dihydrochloride
D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D010919:Placebos; D013450:Sulfones; D014227:Triazines; D000069058:Vardenafil Dihydrochloride